Year: All Releases2018201720162015201420132012 May 22, 2018 Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1522 at the 2018 American Society of Clinical Oncology Annual Meeting PDF Version May 14, 2018 Mersana Therapeutics Announces First Quarter 2018 Financial Results and Provides Business Updates PDF Version May 7, 2018 Mersana Therapeutics to Host Conference Call Announcing First Quarter 2018 Financial Results and Business Updates PDF Version May 1, 2018 Mersana Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference PDF Version April 17, 2018 Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018 PDF Version April 9, 2018 Mersana Therapeutics Announces Poster Presentations Demonstrating Differentiating Aspects of ADC Platform Technology at the American Association for Cancer Research Annual Meeting 2018 PDF Version March 28, 2018 Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates PDF Version March 21, 2018 Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business Updates PDF Version March 19, 2018 Mersana Strengthens Board of Directors Leadership with Appointment of Willard H. Dere, M.D., Professor at the University of Utah and Retired Chief Medical Officer of Amgen PDF Version March 12, 2018 Mersana Appoints David A. Spellman as Chief Financial Officer PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
